Filing Details
- Accession Number:
- 0001140361-16-082615
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-12 19:01:13
- Reporting Period:
- 2016-10-10
- Filing Date:
- 2016-10-12
- Accepted Time:
- 2016-10-12 19:01:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1444380 | Nevro Corp | NVRO | Surgical & Medical Instruments & Apparatus (3841) | 562568057 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1613689 | Rami Elghandour | C/O Nevro Corp. 1800 Bridge Parkway Redwood City CA 94065 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-10-10 | 3,000 | $3.60 | 67,180 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-10-10 | 3,000 | $100.00 | 64,180 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2016-10-10 | 3,000 | $0.00 | 3,000 | $3.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
75,051 | 2023-05-14 | No | 4 | M | Direct |
Footnotes
- Includes 63,695 RSUs.
- The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- The option, representing the right to purchase 88,207 shares of the Issuer's common stock, vests and becomes exercisable in respect to 1/48th of the original number of shares subject to the option on each monthly anniversary measured from May 15, 2013 (the "Vesting Commencement Date"), such that 100% of the shares underlying the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.